arrow
K

Krzysztof Dudek

wrocław university of science and technology
H指数:27
被引数:2,339

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term outcomes of allogeneic hematopoietic stem cell transplantation in adult philadelphia chromosome-positive all treated with tyrosine kinase inhibitors in the pre-blinatumumab era. A retrospective analysis on behalf of the polish adult leukemia group

成人费城染色体阳性急性淋巴细胞白血病在blinatumumab问世前接受酪氨酸激酶抑制剂治疗并实施异基因造血干细胞移植的长期预后:波兰成人白血病组的回顾性分析

2026-05-010
PRE
Soluble B-Cell Maturation Antigen as a Prognostic Marker for Progression-Free Survival in Multiple Myeloma Treated with BCMA-Directed Therapies: A Systematic Review and Meta-Analysis

可溶性B细胞成熟抗原作为接受BCMA靶向治疗的多发性骨髓瘤患者无进展生存期的预后标志物:一项系统评价和Meta分析

Cancers
IF4.4
2026-02-260
OAAI
Neuropilin-1 expression in primary and metastatic prostate cancer: Expression patterns and clinicopathological correlations

神经纤毛蛋白-1在原发性和转移性前列腺癌中的表达:表达模式与临床病理相关性

2025-10-010
OAAI
Impact of First- and Second-Generation Tyrosine Kinase Inhibitors on the Development of Graft-Versus-Host Disease in Individuals with Chronic Myeloid Leukemia: A Retrospective Analysis on Behalf of the Polish Adult Leukemia Group

第一代和第二代酪氨酸激酶抑制剂对慢性粒细胞白血病患者移植物抗宿主病发展的影响: 代表波兰成人白血病组的回顾性分析

2025-01-110
OAAI
Optimizing Outcomes in Mismatched Unrelated Donor Allogeneic Transplantation: Post-Transplant Cyclophosphamide's Dual Impact on Graft versus Host Disease Incidence and Overall Survival: Retrospective Analysis on Behalf of Polish Adult Leukemia Group
2024-06-180
OAAI